Laboratory diagnosis of sexually transmitted infections in women with genital discharge in Madagascar: implications for primary care

被引:12
作者
Behets, FMTF [1 ]
Andriamiadana, J [1 ]
Randrianasolo, D [1 ]
Rasamilalao, D [1 ]
Ratsimbazafy, N [1 ]
Dallabetta, G [1 ]
Cohen, MS [1 ]
机构
[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA
关键词
diagnosis; cervical infections; discharge; primary care; antimicrobial susceptibility;
D O I
10.1258/09564620260216308
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Women seeking care in Madagascar for genital discharge (n = 1066) were evaluated for syphilis seroreactivity; bacterial vaginosis (BV) and trichomoniasis. Chlamydial infection was assessed by ligase chain reaction (LCR) and by direct immunofluorescence (IF); gonorrhoea by direct microscopy, culture and LCR. Leucocytes were determined in endocervical smears and in urine using leucocyte esterase dipstick (LED). Gonococcal isolates were tested for minimal inhibitory concentrations. BV was found in 56%, trichomoniasis in 25%, and syphilis in 6% of the women. LCR detected gonorrhoea in 13%, and chlamydial infection in 11% of the women. Detection of Gram(-) intracellular diplococci in endocervical smears, and gonococcal culture were respectively 23% and 57% sensitive and 98% and 100%, specific compared to LCR. Chlamydia antigen detection by IF was 75%, sensitive and 77% specific compared to LCR. Leucocytes in endocervical smears and LED testing lacked precision to detect gonococcal and chlamydial infections. Of 67 gonococcal strains evaluated, 19% were fully susceptible to penicillin, 33%, to tetracycline; all were susceptible to ciprofloxacin, ceftriaxone, and spectinomycin. Patients who present with genital discharge in Madagascar should be treated syndromically for gonococcal and chlamydial infections and screened for syphilis. Gonorrhoea should be treated with ciprofloxacin.
引用
收藏
页码:606 / 611
页数:6
相关论文
共 24 条
[1]  
[Anonymous], METH DIL ANT SUSC TE
[2]   High syphilis and low but rising HIV seroprevalence rates in Madagascar [J].
Behets, FMT ;
Andriamahenina, R ;
Andriamiadana, J ;
May, JF ;
Rasamindrakotroka, A .
LANCET, 1996, 347 (9004) :831-831
[3]  
BOGAERTS J, 1993, GENITOURIN MED, V69, P196
[4]   Reappraising the value of urine leukocyte esterase testing in the age of nucleic acid amplification [J].
Bowden, FJ .
SEXUALLY TRANSMITTED DISEASES, 1998, 25 (06) :322-326
[5]   Newly available and future laboratory tests for sexually transmitted diseases (STDs) other than HIV [J].
Chernesky, M ;
Morse, S ;
Schachter, J .
SEXUALLY TRANSMITTED DISEASES, 1999, 26 (04) :S8-S11
[6]  
EHRET JM, 1991, LAB METHODS DIAGNOSI, P54
[7]  
EVANS JK, 1994, GENITOURIN MED, V70, P291
[8]  
FLETCHER RH, 1998, CLIN EPIDEMIOLOGY, P246
[9]   IMPACT OF IMPROVED TREATMENT OF SEXUALLY-TRANSMITTED DISEASES ON HIV-INFECTION IN RURAL TANZANIA - RANDOMIZED CONTROLLED TRIAL [J].
GROSSKURTH, H ;
MOSHA, F ;
TODD, J ;
MWIJARUBI, E ;
KLOKKE, A ;
SENKORO, K ;
MAYAUD, P ;
CHANGALUCHA, J ;
NICOLL, A ;
KAGINA, G ;
NEWELL, J ;
MUGEYE, K ;
MABEY, D ;
HAYES, R .
LANCET, 1995, 346 (8974) :530-536
[10]   PATTERN OF SEXUALLY-TRANSMITTED DISEASES IN A MALAGASY POPULATION [J].
HARMS, G ;
MATULL, R ;
RANDRIANASOLO, D ;
ANDRIAMIADANA, J ;
RASAMINDRAKOTROKA, A ;
KIRSCH, T ;
HOF, U ;
RARIVOHARILALA, E ;
KORTE, R .
SEXUALLY TRANSMITTED DISEASES, 1994, 21 (06) :315-320